Full metadata record
DC poleHodnotaJazyk
dc.contributor.authorStros, Michael
dc.contributor.authorŘíha, David
dc.date.accessioned2020-09-02T09:36:03Z
dc.date.available2020-09-02T09:36:03Z
dc.date.issued2020
dc.identifier.citationTrendy v podnikání = Business trends : vědecký časopis Fakulty ekonomické ZČU v Plzni. 2020, roč. 10, č. 1, s. 73-86.cs
dc.identifier.issn1805-0603
dc.identifier.urihttps://drive.google.com/file/d/18zbqrh1xul1WAnlTwzrafu_iBXiTQjbl/view
dc.identifier.urihttp://hdl.handle.net/11025/39596
dc.format14 s.cs
dc.format.mimetypeapplication/pdf
dc.language.isoenen
dc.publisherZápadočeská univerzita v Plznics
dc.rights© Západočeská univerzita v Plznics
dc.subjectocenění společnostics
dc.subjectfinancecs
dc.subjectrůstové společnostics
dc.subjectfarmaceutický obchodcs
dc.subjectstrategiecs
dc.titleWhat is the value of growth companies? A methodical approach to the valuation of growth companies in the biotechnology and pharmaceutical sectoren
dc.typečlánekcs
dc.typearticleen
dc.rights.accessopenAccessen
dc.type.versionpublishedVersionen
dc.description.abstract-translatedIn the case of company takeovers, a comprehensive company valuation is an indispensable prerequisite for determining the actual value of the company. This is particularly important in times of increased company takeovers. Classical valuation methods, however, only take into account the financial situation, and other factors are not usually taken into account. The question therefore arises as to how a more comprehensive company valuation can be ensured. Theoretical concepts from business administration form a suitable basis to carry out a more comprehensive, holistic view of the company. This paper develops a comprehensive methodological approach for the valuation of growth companies. Aspects of the company to be evaluated that go beyond the financial aspects are included. Strategy, technology, organization and management skills as well as cooperation with other companies are fundamental components of this valuation approach in addition to the financial situation. A practical company example from the biotechnology sector is used to illustrate the application of the valuation approach.en
dc.subject.translatedcompany valuationen
dc.subject.translatedfinanceen
dc.subject.translatedgrowth companiesen
dc.subject.translatedpharmaceutical businessen
dc.subject.translatedstrategyen
dc.identifier.doihttps://doi.org/10.24132/jbt.202.10.1.73_86
dc.type.statusPeer-revieweden
Vyskytuje se v kolekcích:Číslo 1 (2020)
Číslo 1 (2020)

Soubory připojené k záznamu:
Soubor Popis VelikostFormát 
8_Stros_Riha.pdfPlný text488,52 kBAdobe PDFZobrazit/otevřít


Použijte tento identifikátor k citaci nebo jako odkaz na tento záznam: http://hdl.handle.net/11025/39596

Všechny záznamy v DSpace jsou chráněny autorskými právy, všechna práva vyhrazena.